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While some neurotropic viruses cause rapid central nervous system (CNS) disease upon entry into the brain parenchyma, other viruses
that are cytolytic in the periphery either result in little neuropathology or are associated with a protracted course of CNS disease consistent
with persistent infection. One such virus, poliovirus (PV), is an extremely lytic RNA virus that requires the expression of CD155, the
poliovirus receptor (PVR), for infection. To compare the kinetics of PV infection in neuronal and non-neuronal cell types, primary
hippocampal neurons and fibroblasts were isolated from CD155+ transgenic embryos and infected with the Mahoney and Sabin strains of PV.
Despite similar levels of infection in these ex vivo cultures, PV-infected neurons produced 100-fold fewer infectious particles as compared to
fibroblasts throughout infection, and death of PV-infected neurons was delayed approximately 48 h. Spread in neurons occurred primarily by
trans-synaptic transmission and was CD155-dependent. Together, these results demonstrate that the magnitude and speed with which PV
replication, spread, and subsequent cell death occur in neurons is decreased as compared to non-neuronal cells, implicating cell-specific
effects on replication that may then influence viral pathogenesis.
D 2005 Elsevier Inc. All rights reserved.Keywords: Poliovirus; CD155; Primary neurons; Mouse embryonic fibroblasts; CNS; Viral spread; Trans-synaptic transmissionIntroduction
Poliovirus (PV) is an enterovirus belonging to the family
Picornaviridae and is the etiological agent of poliomyelitis
in humans. PV possesses a positive strand RNA genome of
approximately 7.5 kb, packaged in a non-enveloped
icosahedral protein capsid (Hogle et al., 1985). The capsid
consists of 60 copies of each of four virally encoded
structural proteins VP1, VP2, VP3, and VP4. The icosahe-
dral structure formed by these capsid proteins produces deep
surface depressions, or Fcanyons_, that have been identified
as receptor binding sites (Colston and Racaniello, 1994,
1995; Hogle et al., 1985; Racaniello and Ren, 1996). PV
infection initiates when the viral particle binds to its cellular
receptor, CD155 (Belnap et al., 2000; He et al., 2000). Upon
binding, the PV particle undergoes a conformational change
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E-mail address: glenn.rall@fccc.edu (G.F. Rall).terminus of the internal VP1 protein is extruded (Everaert et
al., 1989; Fricks and Hogle, 1990; Gomez et al., 1993;
Lonberg-Holm et al., 1975; Wien et al., 1996). It is believed
that the exposure of the hydrophobic N-terminus of the VP1
protein forms a pore in the host cell membrane, allowing the
viral particle to enter the cytoplasm. Additionally, these
conformational changes in the virion result in a reduced
sedimentation coefficient in the viral particle from the native
160S to an infectious intermediate or 135S sub-particle. It is
thought that viral engagement with CD155 triggers this
conformational change (Tsang et al., 2001); however,
whether the loss of VP4 is the basis of the altered
sedimentation coefficient remains debated (Basavappa et
al., 1998).
The normal route of PV infection in naturally permissive
hosts begins with infection of the enteric system through
oral ingestion of the virus. Viral particles initially replicate
in the gastrointestinal system, but replication at this site does
not result in any detectable pathology (Bodian, 1955; Sabin,
1956). In approximately 0.1–1% of acute PV infections, the
virus invades the CNS, producing the paralytic disease005) 10 – 20
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results from PV infection, translational inhibition, and
destruction of motor neurons in the central nervous system
(CNS) and is clinically manifested as limb paralysis.
Interestingly, despite a rapid course of viremia that can be
detected soon after viral exposure, PV appears to adopt a
less productive course in the CNS (Girard et al., 2002;
Minor, 1996). The ability of polio to spread in a somewhat
restricted manner within the CNS may foster the establish-
ment of a slow or persistent infection. While controversial,
this observation has led to suggestions by others that chronic
infection may be linked to diseases such as post-polio
syndrome, in which patients develop signs of poliomyelitis
months to years after primary exposure (Destombes et al.,
1997; Pavio et al., 1996).
The natural expression of CD155 in humans and some
primates, but not in experimental animals such as mice,
limited early studies of PV spread and pathogenesis. In
1990–91, transgenic mice expressing CD155 were estab-
lished; these mice were susceptible to PV infection by all
three viral serotypes (Koike et al., 1991; Ren et al., 1990).
The development of these valuable models was responsible
for substantial advances in our understanding of PV
replication and pathogenesis; however, important aspects
of PV interaction with its natural host remain obscure. For
example, while expression of CD155 is required for
poliovirus entry (Koike et al., 1990; Mendelsohn et al.,
1989), it is not sufficient to confer permissivity, as polio-
virus cannot establish an infection in CD155-expressing
mice by the intra-oral route, despite expression of CD155
within the gut (Ren et al., 1990).
The pathway of PV spread from the periphery to the CNS
in susceptible hosts is not fully understood. As viremia is a
prerequisite for the development of poliomyelitis and
dendritic cells and macrophages can be infected with
poliovirus (Wahid et al., 2005; Buisman et al., 2003;
Freistadt et al., 1993), polio may gain entry to the brain
via transport of infected blood cells across the blood–brain
barrier (BBB) (Yang et al., 1997). A second proposed
mechanism of PV neurotropism is transport along neural
pathways, perhaps provoked by muscle injury at the site of
infection, as in the case of provocation poliomyelitis
(Gromeier and Wimmer, 1998). In immunoelectron micro-
scopy studies of spinal cord sections of mice infected with
the type 2 Lansing strain, PV antigens were primarily
detected in neuronal axons and synapses, suggesting that
spread may be trans-synaptic (DalCanto et al., 1986).
Subsequently, PV was shown to travel to the CNS from
infected muscle tissue in transgenic mice via major nerves,
such as the sciatic nerve (Ponnuraj et al., 1998; Ren and
Racaniello, 1992), providing additional support for trans-
synaptic transmission. The speed of PV spread from the
periphery to the CNS via neuron–neuron interactions was
later shown to be consistent with fast retrograde axonal
transport (Ohka et al., 1998). Interestingly, however, PV
particles isolated from the sciatic nerve were of the intact160S form of the viral particle, not the 135S sub-particles
thought to be required for infection (Arita et al., 1999). One
possible interpretation of these results is that interaction
with the viral receptor may not be required for PV
transmission across the synapse, a theory for which
evidence exists in a model of neuronal infection by another
RNA virus, measles (Lawrence et al., 2000).
Although PV has been studied extensively in vivo, its
replication and spread in purified primary neuron cultures
have not been extensively explored. Based on observations
that PV infection of the CNS is distinct from infection of the
periphery with respect to viral yield and cytopathicity, we
undertook studies to address whether PV adopts an altered
replication profile in purified primary neurons and to further
explore the basis of PV spread in such cultures. Using
highly enriched primary neuron cultures isolated from
CD155+ transgenic embryos, as well as control mouse
embryo fibroblasts (MEFs) obtained from the same animals,
we compared the kinetics of infection of neurons with
MEFs, established the mode of interneuronal viral spread,
and clarified the role played by CD155 in neuronal PV
transport.Results
Poliovirus growth kinetics in permissive neurons and mouse
embryo fibroblasts
To assess PV replication kinetics in different primary cell
cultures, type 1 PV infection by the Sabin strain and the
more virulent Mahoney strain of cultured CD155+ neurons
was compared to infection of mouse embryo fibroblasts
(MEFs) isolated from the same embryos.
To confirm that CD155+ explant cultures indeed express
this receptor, immunofluorescence using a monoclonal
antibody to CD155 was performed on CD155+ and
CD155 cells. As shown in Fig. 1, neurons (A–C) and
MEFs (G–I) isolated from CD155+ transgenic mice were
immunopositive, whereas neurons isolated from CD155
(c57Bl/6) embryos (D–F) were not. The slight background
signal detected in nontransgenic neurons is likely due to
nonspecific binding of the secondary antibody.
PV replication and transmission in CD155+ primary
neurons and MEFs were then examined. Cells were infected
with PV-Sabin or PV-Mahoney (MOI = 0.1); at 8 h
intervals, cells and supernatants were collected and analyzed
for infection by flow cytometry and immunocytochemistry
(Figs. 2A and B), extent of cell death by cellular
morphology and counting of residual live cells (Fig. 2C),
and virus production by plaque assay and infectious center
assay (Fig. 3). As shown by flow cytometry (Fig. 2A) at 24
and 40 h post-infection (hpi), the extent of infection in
MEFs and neurons was comparable. Although more MEFs
were infected at each timepoint evaluated, both neurons and
MEFs became heavily infected over time, and the rate of
Fig. 1. CD155 expression in primary hippocampal neurons and mouse embryonic fibroblasts (MEFs). CD155+ primary hippocampal neurons (A–C) and
mouse embryonic fibroblasts (G– I) were prepared from PVR transgenic mice. CD155 control neurons (D–F) were prepared from c57Bl/6 mice. All cells
were immunostained for CD155 expression. Phase (A, D, G), fluorescence (B, E, H), and merged (C, F, I) are shown. Representative images were taken from
one of three identical experiments. Magnification: 100.
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strain, 72% and 84% of MEFs were immunopositive at 24
and 40 hpi respectively, compared to 36% and 58%
infection of neurons (Fig. 2A; Table 1). Although the
number of antigen-positive cells was lower following
infection by the less virulent Sabin strain, a similar profile
of infection was observed. Interestingly, two distinct peaks
were observed in the FACScan histograms of Sabin-infected
MEFs at 40 hpi (Fig. 2A); this was also observed as two
immunopositive populations that differed in staining inten-
sity (Fig. 2B, panels k and m).
Despite efficient PV infection and spread in both cell
types, virus-induced cytopathicity in neurons was reduced as
compared with matched infected MEFs (Fig. 2C). For these
studies, the number of live and dead cells was determined at
each timepoint by morphology, TUNEL staining, or trypan
blue exclusion. Mahoney infection of MEFs was highly
lytic, killing virtually all infected cells by 24 hpi (Fig. 2B,
panel e; Fig. 2C). In contrast, neuronal infection at this same
timepoint was not associated with extensive cell loss (Fig.Fig. 2. PV spread and cytotoxicity in primary neurons and fibroblasts. (A) Flow cy
neurons at 24 and 40 hpi. As described in Materials and methods, cells were labeled
antibody. PV-infected: blue lines; uninfected: red lines. (B) CD155+ MEFs (a, c, e,
strain (a–b, e– f, i – j) or Sabin strain (c–d, g–h, k–m) of PV (MOI = 0.1) and
immunostaining using a monoclonal antibody to PV and visualized by DAB precip
arrowheads denote high-expressing cells. Representative images from one of three
(C) The total number of live and dead cells was ascertained, as determined by cel
was independently confirmed by trypan blue exclusion and absence of TUNEL stai
(right) at 0, 16, 24, and 40 hpi. Black bars: MEFs; stippled bars: neurons.2B, panel f; Fig. 2C), and even at 40 hpi, neuronal death was
still less than 50% (Fig. 2B, panel j). Although MEF cell
death was less pronounced with the Sabin strain, most
infected MEFs showed signs of nuclear condensation and
rounding (Fig. 2B, panels g and k), whereas neurons at the
same timepoints appeared healthy, with intact processes
(panels h and l). Thus, while neurons eventually do die as a
result of PV infection with both strains, virus-induced
cytopathicity was noted significantly earlier in MEFs than
in neurons: dying fibroblasts were seen as early as 8–16 hpi
for both strains of PV; in contrast, neuronal cytopathicity was
not observed until 36–48 hpi, and even at this late timepoint,
viable neurons were abundant.
The delay in PV-induced cytopathic effect (CPE) in
neurons was consistent with a 100- to 500-fold decrease in
extracellular infectious viral titers, relative to matched MEFs
(Fig. 3A). For example, in the representative experiment
shown (of five such experiments), at 24 hpi, MEF titers
following PV-Mahoney challenge were 9  107 PFU/ml as
compared to neuronal titers of 2  105 PFU/ml. Thoughtometry was performed on single cell suspensions of PV-infected MEFs and
with anti-PVantibodies and visualized with an FITC-conjugated secondary
g, i, k, m) and neurons (b, d, f, h, j, l) were infected with either the Mahoney
collected at 16, 24, and 40 h post infection. PV antigen was detected by
itation. For panel (m), arrows denote low antigen-expressing cells, whereas
identical experiments are shown. Magnification: (a– l): 100; (m): 400
lular morphology, TUNEL staining, and/or trypan blue exclusion. Viability
ning (data not shown). Results are shown for both Mahoney (left) and Sabin.
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Fig. 3. Poliovirus-infected primary neuron cultures produce less extra-
cellular infectious virus than infected MEFs. (A) Equivalent numbers of
MEFs and primary neurons were plated and infected with PV-Mahoney or
Sabin, as described. At the indicated times post-infection, supernatants were
collected, and plaque assays were performed; data are presented as log
PFU/ml. A representative experiment of five is shown. Black circles:
Mahoney titers in MEFs; white circles: Mahoney titers in neurons; black
triangles: Sabin titers in MEFs; white triangles: Sabin titers in neurons. (B)
The average number of viral particles produced per infected cell was
calculated for each timepoint post-infection with PV-Mahoney. These
values were obtained by dividing the amount of total extracellular virus by
the total number of immunopositive cells in the cultures. Black bars: MEFs;
stippled bars: neurons. ND = none detected.
Table 1
Infectious center analysis of PV-infected neurons and fibroblasts
HPI Neurons Fibroblasts
% Infected PFU/infected cell % Infected PFU/infected cell
16 22 0.13 64.9 1.13
24 32.6 0.33 77.6 0.92
32 46.3 1.1 85 4.95
Primary neurons and fibroblasts were cultured and infected with PV-
Mahoney as described in Materials and methods. Infectious center assays
were performed on the infected cells, and the percent of infected cells
determined. The total PFU in the supernatants (determined by plaque assay)
was then divided by this value to obtain PFU/infected cell.
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both cell types, overall differences in titer between the two
cell populations remained consistent. This difference was
also apparent on a per-infected cell basis; as indicated in the
representative Mahoney experiment shown in Fig. 3B (one of
four such experiments), approximately 20-fold more infec-
tious PV particles were produced in MEFs than in neurons.
Similar results were obtained when identical comparisons
were done with the Sabin strain of PV (data not shown).
To confirm that antigen-positive cells were productively
infected with PV, infectious center assays were performed.
As shown in Table 1, at 32 h post-infection with PV-
Mahoney, fibroblasts produced approximately 5 PFU/
infected cell, whereas neurons produced only 1 particle/
infected cell, mirroring the data obtained by histochemistry.
Thus, by both immunochemical and functional assays, theextent of infection and the magnitude of infectious particles
produced were substantially reduced in neurons as com-
pared to control fibroblasts.
Interneuronal poliovirus spread is primarily trans-synaptic
In a mouse model of neuronal infection by measles virus,
reduced cytopathicity was associated with selective trans-
mission at the synapse (Lawrence et al., 2000). To determine
if a similar process was occurring for PV, we turned our
attention to the basis of spread in these primary cultures.
Immunocytochemical data indicated that clusters of infected
neurons were connected by antigen-positive processes (e.g.,
Fig. 2B, panels b, f, j, and l), supporting studies that
demonstrated trans-synaptic spread in vivo (Ohka et al.,
1998; Ren and Racaniello, 1992). These immunopositive
processes were not observed when poliovirus-challenged
control PVR neurons were stained for PV antigen (data not
shown). To ascertain the relative contributions of extra-
cellular virus and trans-synaptic transfer to PV spread in
infected neurons, neutralizing antibodies were employed.
Serum from previously infected PVR+ transgenic mice
(greater than 25 days post-infection) was used; similar
experiments were repeated with a commercially available
type 1 neutralizing antibody (BioSource) with identical
results. The neutralizing antiserum was added to the cultures
1 h post-infection with PV-Sabin (MOI = 0.1); cells and
supernatants from antibody-treated and non-treated cultures
were collected at 24 and 32 h post-infection and were
immunostained for PV antigens as described previously. As
shown in Fig. 4A, addition of neutralizing antibodies
reduced viral titers by greater than 2 orders of magnitude
for both cell types. For neurons, this represented a decline in
titers from 105 to 103, and for fibroblasts, a decline from 106
to 103.5. Different sources of antibodies, combinations of
antibodies, or addition of higher doses did not appreciably
decrease viral titers further (data not shown).
As expected, the presence of PV neutralizing antibody in
infected MEF cultures almost entirely inhibited viral spread,
reducing the percent of immunopositive cells at 24 hpi from
>50% to <10% (Figs. 4B and C, panels a and b). Note that,
since the neutralizing antibody was added to the cultures
after viral challenge, cells infected by the original inoculum
Fig. 4. Poliovirus spread in infected CD155+ neuron cultures occurs in the
presence of type 1 PV neutralizing antibody. (A) Supernatants from PV
Sabin-infected MEFs and neurons, in the presence or absence of type 1 PV
neutralizing antibody, were collected and assayed for infectious particles
by plaque assay through 32 hpi. Black bars: no neutralizing antibody;
stippled bars: antibody added. The experiment shown is representative of
three experiments. (B) CD155+ MEFs and neurons infected with PV-Sabin
(MOI = 0.1) were incubated for 16 and 24 hpi in the presence or absence
of type 1 PV neutralizing antibody, and the percent of infected cells was
then determined by immunocytochemistry. (C) CD155+ MEFs (a, b) and
neurons (c, d) were infected with PV-Sabin (MOI = 0.1) and were
incubated for 24 h with (+) or without () PV type 1 neutralizing
antibody. PV antigen was visualized as described in Materials and
methods. Magnification = 100.
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neutralizing antibody in neuron cultures infected with PV-
Sabin had virtually no impact on viral spread in infectedneurons (Figs. 4B and C, panels c and d). Similar
observations were obtained following treatment of Mahoney
virus-infected cultures (data not shown). Thus, the absence
of an effect on viral spread in neurons, despite a significant
impact on extracellular viral levels following neutralizing
antibody treatment, supports the hypothesis that the
predominant mode of spread in neurons is by trans-synaptic
transmission. Because the neutralizing antibody did not
completely eliminate extracellular virus, we cannot formally
exclude the possibility that some spread in neuron cultures
was due to residual infectious particles; however, this seems
unlikely as spread in MEFs in the presence of the antibody
was completely ablated and neuronal spread still occurred
efficiently in antibody-treated neuron and MEF co-cultures
(data not shown).
Poliovirus spread between infected CNS neurons requires
the expression of CD155
CD155 is required for initiation of PV infection in
susceptible mice (Koike et al., 1991; Ren et al., 1990).
However, it is not clear if subsequent PV spread between
neurons requires CD155, as a recent study indicated that
only the intact 160S, and not the ‘‘infectious’’ 135S sub-
viral particle, could be found in the sciatic nerve of infected
mice (Arita et al., 1999). To address this question, primary
neurons from c57Bl/6 mice were loaded with an orange vital
dye and were mixed in varying ratios with unlabeled
CD155+ neurons. These ‘‘mixed’’ neuron cultures were
then infected with either PV-Sabin or PV-Mahoney at an
MOI = 0.1 and were collected and fixed 24 hpi. As shown in
Figs. 5a, d, and g, neurons infected with either Sabin or
Mahoney strains were connected by immunopositive
processes. Nevertheless, no spread to nontransgenic neurons
(Panels 5b and e) was observed when the images were
merged (Figs. 5c and f). This was also true in cultures
collected at 40 hpi, a relatively late timepoint post-infection
(data not shown). As a control, CD155+ neurons were
infected in suspension (Mahoney; MOI = 0.1) and plated
with uninfected, vital-dye-labeled CD155+ neurons in the
presence of neutralizing antibody. As shown in Figs. 5g–i,
spread to vital-dye-labeled neurons occurred readily, as
expected. Thus, we conclude from these experiments that
expression of CD155 is required for both viral entry and
subsequent trans-synaptic spread.Discussion
While many viruses can infect the human CNS, they do
so rarely. For many of these viruses, once access to the CNS
is achieved, the profile of replication is distinct from that in
the periphery: often, a more chronic or persistent infection
occurs, usually associated with a progressive course, as with
measles and the rare but fatal disease, subacute sclerosing
panencephalitis. Poliovirus is the causative agent of polio-
Fig. 5. Interneuronal spread of PV requires the expression of the poliovirus receptor, CD155. c57Bl/6 neurons (b and e) or CD155+ neurons (h) were loaded
with an orange vital dye and plated with unlabeled, PV-infected CD155+ neurons (Sabin: a; Mahoney: d, g). After 24 h, the neurons were fixed and
immunostained for PV antigen using an FITC-conjugated secondary antibody. (a, d and g) PV-infected neurons; (b, e, and h) vital dye-labeled neurons; (c, f,
and i) merge. Magnification = 100.
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of motor neurons that results in limb paralysis. In an effort
to determine whether PV replication and spread were
impacted upon neuronal infection, primary cultures from
susceptible PV receptor-expressing transgenic mice were
established, and the infection profiles compared. Two
conclusions can be drawn from the experiments described
in this work. First, the extent of viral cytopathicity and
extracellular virus production is significantly reduced in
neurons compared to MEFs, despite similar levels of
infection. These data support previous observations in
transgenic mice and in established neuroblastoma cells that
PV replication is restricted upon neuronal infection (Cou-
derc et al., 2002; Girard et al., 2002). Secondly, despite the
production of some extracellular viral progeny, the predom-
inant mechanism of PV spread is via trans-synaptic transfer,
a process that is CD155-dependent. The ability of virus to
spread via the synapse (rather than through cell lysis, as
occurs in non-neuronal cells) may contribute to the reduced
cytopathicity of PV within neurons.
The reduced productivity and cytopathicity of both Sabin
and Mahoney strains of PV in neurons are consistent with
observations that many DNA and RNA viruses undergo a
change in the viral replication cycle upon neuronal
infection. For example, upon entry into spinal cord neurons,
herpes simplex virus-1 undergoes a switch to a latent state in
which viral gene expression is virtually ablated (reviewed in
Johnson, 1998). Moreover, MV adopts a noncytolytic, non-
fusogenic, trans-synaptic mode of spread in neurons that is
not associated with the emergence of viral variants
(Lawrence et al., 2000) (Gechman et al., in preparation).
Thus, our observations using PV-infected neurons may
reflect a common mechanism by which neurons restrict ormodulate viral replication. While the reduced productivity
in neurons may be attributable to viral mutations, as
previously shown for some strains of PV (LaMonica and
Racaniello, 1989), other reasonable explanations exist. For
example, it is possible that the cellular machinery available
to viruses upon neuronal entry may be sufficiently unique to
support a different mode of replication. Key differences in
the availability of translation-associated proteins (Guest et
al., 2004), the cellular proteins that are required for viral
budding (Lawrence et al., 2000), the reduced mitotic
capacity of parenchymal cells, and the level of cyclic
nucleotides (Miller and Carrigan, 1982) may impact on viral
replication and resultant pathogenesis. As these studies
continue, it will be of interest to further identify the cellular
factors that influence the poliovirus life cycle in neurons.
Our studies support and extend those of other laborato-
ries who have assessed the spread and pathogenesis of PV in
neurons. While care must be taken not to infer too broadly
from purified primary neurons to the more complex
interaction of poliovirus with other cell types in vivo,
studies from our laboratory and others indicate that such
cultures can reproducibly parallel observations made in
permissive mice. For example, work from Blondel and
colleagues using permissive transgenic mice and mixed
brain cell cultures showed that PV infection of neurons
resulted in apoptosis, as caspase inhibitors prevented cell
death in these cultures (Couderc et al., 2002; Girard et al.,
1999). Consistent with our observations of delayed neuronal
death, apoptosis in mixed cultures was apparent only after
28 hpi. We have since confirmed in our purified cultures that
neuronal loss due to PV infection is attributable to
apoptosis, whereas MEF death is more likely due to classic
virus-induced CPE (data not shown).
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trafficking of PV within neurons. Wimmer and colleagues
have reported that the cytoplasmic domain of the CD155
receptor binds to Tctex-1 (Mueller et al., 2002), a light chain
of the dynein motor complex that governs retrograde
transport in polarized cells. The apparent ‘‘hand-off’’ of
the incoming viral particle to molecular motor proteins
likely facilitates the fast retrograde axonal transport used by
PV in vivo to spread from muscle to the CNS through the
sciatic nerve (Ohka et al., 1998, 2004). Given that the
mature 160S form of PV was isolated from infected nerves
(Arita et al., 1999; Ohka and Nomoto, 2001; Ohka et al.,
1998), it was possible that the interaction of PV with its
receptor may be either different at the synapse than at the
plasma membranes of non-neuronal cells or that CD155
may be dispensable for viral spread altogether. As support
for the latter hypothesis, our laboratory previously demon-
strated that measles virus, while requiring a receptor to
initially infect neurons, could spread from infected neurons
to uninfected neurons in a receptor-independent manner
(Lawrence et al., 2000). Our studies here indicate that
CD155 is required for neuron-to-neuron spread; therefore, if
the interneuronal spread of poliovirus is distinct from
infection by an extracellular particle, it is nevertheless
CD155-dependent.
The delayed course to PV-induced cytolysis and reduced
viral productivity that we observed in cultured neurons may
have direct bearing on the development of persistent
infection within the CNS. Several studies have demonstra-
ted that PV RNA can persist in susceptible mouse neurons,
both in vivo (Destombes et al., 1997) and in vitro (Pavio et
al., 1996). Moreover, PV RNA has been detected in human
cerebrospinal fluid from individuals who previously had an
acute case of poliomyelitis (Leparc-Goffart et al., 1996).
PV remains high on the World Health Organization’s list
of viruses to be eradicated in the near future, and some have
argued that the risks of a sustained vaccination program are
greater than the risks of viral recrudescence. Nevertheless,
as recently seen with outbreaks of MV in England, viruses
can make a rapid and serious recurrence in populations with
declining vaccine coverage. The diseases associated with
PV infection, including both the risk of poliomyelitis in the
short term and post-polio syndrome in the long term, argue
in favor of further studies to define the interaction of this
virus with its cellular host.Materials and methods
Cells and viruses
Poliovirus receptor (PVR; CD155+) transgenic mice,
originally developed by Racaniello and colleagues (Ren et
al., 1990), were obtained from Luis Sigal at Fox Chase.
Primary hippocampal neurons were prepared from day 15.5
CD155+ transgenic embryos, as previously described(Banker and Goslin, 1991; Pasick et al., 1994; Rall et al.,
1995), with the exception that cells were maintained in
neurobasal medium (Life Technologies, Grand Island, NY)
containing 4 Ag/ml glutamate, in the absence of an astrocyte
feeder layer. These mixed sensory and motor neuron
cultures are routinely >95% pure, as determined by staining
with microtubule-associated protein-2 (MAP-2) (data not
shown). For all studies in this report, plated neurons were
allowed to differentiate for 72–96 h before infection,
coinciding with the formation of functional synapses and
expression of neuron-specific markers (Rall et al., 1995).
Mouse embryonic fibroblasts (MEFs) were prepared
from the same day 15.5 CD155+ transgenic embryos.
Briefly, livers were removed, and the remaining tissues
were then finely minced in 10 ml of 0.4% trypsin followed
by trituration with a 10 ml pipette. The single cell
suspension was incubated at 37 -C for 10 min, washed
and re-trypsinized. After large tissues pieces were allowed
to settle and were discarded, the resulting cell suspension
was pelleted by centrifugation at 1100 rpm for 5 min. The
resulting pellet was resuspended in complete DMEM (Life
Technologies, supplemented with 5% FCS, 2 mM l-
glutamine, 100 U/ml penicillin, and 100 ng/ml streptomy-
cin) and plated into culture flasks. Vero fibroblasts were also
cultured in complete DMEM. All cells were maintained at
37 -C in a humidified incubator with 5% CO2 and were
routinely tested for mycoplasma contamination.
The Sabin and Mahoney strains of type 1 poliovirus (PV)
were a gift from Luis Sigal and were passaged and titered in
Vero fibroblasts.
Infections
Primary neurons and MEFs were plated onto poly-l-
lysine-treated 15-mm-diameter glass coverslips at a density
of 500 cells/mm2. Neurons were differentiated for 72–96 h
prior to infection, whereas MEFs were plated 24 h before
infection. Cells were infected with type 1 PV, Sabin or
Mahoney strain, at a multiplicity of infection (MOI) = 0.1.
The coverslips were covered with the viral inoculum and
incubated for 1 h at 37 -C, after which the inoculum was
replaced with either conditioned neurobasal medium (pri-
mary neurons) or fresh complete DMEM (MEFs). Slips and
supernatants were collected every 8 h after infection. Slips
were washed briefly in fresh PBS, and the cells were fixed
for 5 min in a 1:1 solution of ice-cold methanol: acetone.
After fixation and drying, the slips were stored at 4 -C in
PBS.
Immunofluorescence
To detect CD155 expression, a mouse antibody to
CD155 (BioSource International, Camarillo, CA) was used
at a 1:100 dilution followed by an Alexa-Fluor 488
conjugated anti-mouse IgG (Molecular Probes, Eugene,
OR; 1:500).
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isolated from c57Bl/6 day 15.5 embryos as described above,
counted, and loaded with Vybrant CMDil cell labeling
solution (Molecular Probes). The vital dye was added to
neurons in suspension at a concentration of 5 Al/2.0  106
cells/ml in serum-free neurobasal media and incubated at
37 -C for 30 min. Labeled neurons were then washed twice
in fresh serum-free neurobasal medium and centrifuged
through a 2 ml FCS cushion. Immunofluorescence detection
of PV antigen utilized a type 1 PV-specific mouse
monoclonal (Accurate, Westbury NY; 1:200 dilution in
PBS) followed by incubation with a biotinylated anti-mouse
IgG2a (Serotec, Raleigh NC; 1:300 dilution in PBS). Finally,
an FITC-conjugated avidin (1:500 dilution; Vector, Burlin-
game, CA) was incubated with the slips for 30 min followed
by three 5 min washes.
All slides were visualized using a Nikon fluorescence
microscope model TE300, equipped with appropriate
filters for the fluorescence studies. For the viral traffick-
ing studies, fluorescent orange and green images from
identical fields were captured and merged using Adobe
Photoshop.
Immunohistochemistry
Fixed cells were blocked with 1% (vol/vol) goat serum in
PBS, further blocked with avidin and biotin (Vector), and
stained for PV antigens as described above. However, after
incubation with the secondary antibody, a streptavidin–
peroxidase conjugate (Vector) was added, and PV was
visualized by diaminobenzidine precipitation (0.7 mg/ml
DAB with 1.6 mg/ml H2O2 in 60 mM Tris; Sigma
Chemical). In some cases, cells were counterstained with
hematoxylin to visualize nuclei. To quantify cell death in
infected cultures, live and dead cells (as determined by
morphology) were counted from 5 representative fields at
400 for each timepoint post-infection. Samples were
coded until after counting.
Flow cytometry
Primary PVR+ hippocampal neurons and MEFs were
plated on poly-l-lysine-treated 6-well culture plates at a cell
density of 500 cells/mm2. Cells were infected with the
Mahoney or Sabin strain of PV at an MOI = 0.1 or were
mock-infected. Cells were removed from the plates at 24
and 40 hpi using Cell Stripper (Cellgro Mediatech, Inc.,
Herndon, VA). Cells were pelleted at 1200 rpm for 5 min
and resuspended in 2 ml cytofix/cytoperm buffer (BD
Biosciences/Pharmingen, San Diego, CA) and incubated for
20 min at 4 -C. Cells were then washed twice with perm/
wash buffer and transferred to wells of a 96-well microtiter
plate. Poliovirus type 1 antibody at a 1:100 dilution or PBS
(for no primary control) was added to each well for 30 min
at 4 -C. An anti-mouse IgG FITC-conjugated secondary
antibody (Vector; 1:500) was added to all wells for 30 minat 4 -C. Cells were centrifuged and resuspended in 400 Al of
0.5% formaldehyde in PBS and analyzed on a BD FACScan
fluorescence-activated cell scanner.
Plaque assay
Supernatants from infected cells were serially diluted and
added to Vero fibroblasts plated in 6-well cell culture dishes
in complete DMEM at a cell density of 106 cells/well. After
incubation at 37 -C for 1 h, the viral inoculum was removed,
and the cells were covered with a 1:1 mixture of 2
Medium 199 (Life Technologies) and 1% molten agarose in
water. The agarose was allowed to solidify, and the plates
were then returned to the 37 -C incubator. Two days later,
the cells were fixed with 10% formaldehyde in PBS.
Agarose overlays were removed, and plaques were visual-
ized by staining the remaining fibroblasts with 0.1% crystal
violet.
Infectious center assay
Infectious center assays (ICA) were performed using
PVR+ neurons and MEFs that were infected with the
Mahoney strain of poliovirus at an MOI = 0.1. At 16, 24,
and 32 hpi, supernatants were removed and assayed for
infectious PV particles by plaque assay (see above). The
attached cells from each timepoint were subsequently
washed with PBS and removed with 0.4% trypsin (2 ml
final volume). The cells were counted (to obtain the total
number of cells), serially diluted, and added to Vero
fibroblasts plated on 6-well cell culture dishes. Two days
post-plating, the cells were fixed and subsequently visual-
ized with crystal violet. The percentage of infected cells was
calculated using the following equation: # of plaques (from
ICA)  dilution factor / total number of cells. Infectious
virus per-infected cell was calculated using the following
equation: total amount of infectious virus released (deter-
mined by plaque assay) / # of infected cells (determined by
ICA).
Neutralizing antibody assay
CD155+ MEFs and neurons, plated on coverslips, were
infected with the Sabin strain of PV at an MOI = 0.1 as
described above. For some slips, 30 Al of type 1 PV
neutralizing antibody (1:320; BioSource) was added 1 h
post-infection. Infected cells and corresponding superna-
tants were collected at various times post-infection. Cover-
slips were fixed and immunostained for PV antigen as
described above; supernatants were subjected to plaque
assay. The percent of infected cells at each timepoint was
calculated by counting 5 representative fields/slip at 400
magnification; identification of the slips was coded until
after counting. Viral titers from each timepoint were
determined by plaque assay of supernatants from infected
cells as described above.
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